CRISM Therapeutics Balance Sheet Health
Financial Health criteria checks 4/6
CRISM Therapeutics has a total shareholder equity of £2.1M and total debt of £0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are £2.4M and £351.0K respectively.
Key information
0%
Debt to equity ratio
UK£0
Debt
Interest coverage ratio | n/a |
Cash | UK£1.86m |
Equity | UK£2.07m |
Total liabilities | UK£351.00k |
Total assets | UK£2.42m |
Recent financial health updates
Financial Position Analysis
Short Term Liabilities: CRTX's short term assets (£2.3M) exceed its short term liabilities (£351.0K).
Long Term Liabilities: CRTX has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: CRTX is debt free.
Reducing Debt: CRTX has no debt compared to 5 years ago when its debt to equity ratio was 5.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CRTX has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: CRTX has less than a year of cash runway if free cash flow continues to grow at historical rates of 8.6% each year.